Serum levels of squamous cell carcinoma antigen SCC, carcinoembryonic antigen CA 125,
and tissue polypeptide antigen were determined in 142 patients with primary cervical …

In the present study we evaluated the clinical usefulness of the tumor antigens, squamous
cell carcinoma antigen (SCC) and ovarian carcinoma antigen (CA 125), in populations of …

Background. We wanted to investigate the clinical usefulness of determining the
pretreatment levels of multiple serum tumor markers in predicting lymph node status and the …

Serum levels of squamous cell carcinoma antigen (SCC), CA 125 and CA 15.3 were
measured in 102 patients with locally advanced cervical cancer undergoing neoadjuvant …

Staging of cervical cancer is routinely performed by means of examination under anesthesia
in combination with radiographic and/or endoscopic techniques. This “clinical” staging leads …

Serum levels of CA-125 and squamous cell carcinoma-associated antigen (SCC) were
measured in 30 patients with squamous cell carcinoma and 12 patients with …

The serum concentration of squamous‐cell carcinoma antigen (SCC‐A), a subfraction of
tumour antigen, was determined by RIA from healthy donors (control group) and from …

A review is given of the clinical use and interpretation of serum tumor marker levels during
the treatment of patients with cancer of the uterine cervix. Pretreatment serum squamous cell …

Squamous cell carcinoma (SCC) antigen was first described by Kato et al. in patients with
carcinoma of the cervix uteri. SCC serum levels can be measured with a radioimmunoassay …

SUMMARY Between 1978 and 1987, 439 patients with primary cervical carcinoma were
admitted to our department. Seventy-seven patients (17.5%) had cervical adenocarcinoma …